NEWSFEEDS: Pfizer walks away from $118 billion AstraZeneca takeover fight      See you later? Slim Pfizer deal hopes prop up AstraZeneca      AstraZeneca rejects Pfizer's take-it-or-leave-it offer      Pfizer raises bid for AstraZeneca to $117 billion      Pfizer pledges to ringfence key new drugs in AstraZeneca deal      UK lawmakers give Pfizer stick as it waves carrot at AstraZeneca      Pfizer defends 'powerhouse' Astra deal as CEO braces for grilling      UK research foundation concerned about Pfizer bid for AstraZeneca: FT      Molycorp slumps 17 percent to record low on bigger quarterly loss      AMC Networks forecasts slower advertising growth      Cheetah Mobile shares rise about 13 percent in debut      'Candy Crush' maker King serves up bittersweet results, shares fall      Fiat Chrysler shares tumble on strategic plan doubts      AstraZeneca takeover would benefit science: Pfizer      Insurer Allianz defends Pimco after investors take flight      HTC shares fall after guidance announcement      Shareholders set to grill Allianz management on Pimco      Twitter shares plumb new lows as stock lock-up expires      AstraZeneca fights Pfizer bid by predicting sales surge - eventually      Lead underwriters start Candy Crush maker with "buy" ratings      AstraZeneca rejects Pfizer's raised bid of $106 billion      Twitter stock slumps 50 percent as Goldman, Deutsche Bank still say `buy'      Pfizer prepares sweeter bid for AstraZeneca: report      3D Systems gross margin slips, shares slide      Peugeot share issue underway as new board meets